MHRA approves first oral advanced therapy for Crohn’s disease
European Pharmaceutical Review
FEBRUARY 2, 2023
Treating Crohn’s disease “There have been limited new treatment options approved for Crohn’s disease in recent years and many people struggle to stay in remission, demonstrating a clear unmet need,” shared Professor James Lindsay, Consultant Gastroenterologist at the Royal London Hospital Barts Health NHS Trust.
Let's personalize your content